Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer

被引：7
|
作者：
Telli, Melinda L. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 29期
关键词：
III RANDOMIZED GEPARTRIO; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; THERAPY; TRIAL; CYCLOPHOSPHAMIDE; PACLITAXEL; EPIRUBICIN;
D O I：
10.1200/JCO.2013.51.0313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3613 / 3615
页数：3
相关论文
共 50 条
  • [31] Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
    Spring, L. M.
    Tolaney, S. M.
    Fell, G.
    Bossuyt, V.
    Abelman, R. O.
    Wu, B.
    Maheswaran, S.
    Trippa, L.
    Comander, A.
    Mulvey, T.
    McLaughlin, S.
    Ryan, P.
    Ryan, L.
    Abraham, E.
    Rosenstock, A.
    Garrido-Castro, A. C.
    Lynce, F.
    Moy, B.
    Isakoff, S. J.
    Tung, N.
    Mittendorf, E. A.
    Ellisen, L. W.
    Bardia, A.
    ANNALS OF ONCOLOGY, 2024, 35 (03) : 293 - 301
  • [32] Response Rates and Survival Prediction in Metastasizing Bladder Cancer after Neoadjuvant Chemotherapy
    Fleischmann, A.
    Perren, A.
    Thalmann, G. N.
    Seiler, R.
    MODERN PATHOLOGY, 2014, 27 : 228A - 228A
  • [33] Response Rates and Survival Prediction in Metastasizing Bladder Cancer after Neoadjuvant Chemotherapy
    Fleischmann, A.
    Perren, A.
    Thalmann, G. N.
    Seiler, R.
    LABORATORY INVESTIGATION, 2014, 94 : 228A - 228A
  • [34] Breast Cancer: Prognosis after neoadjuvant Chemotherapy
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (07)
  • [35] The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
    Yildirim, Sedat
    Dogan, Akif
    Akdag, Goncagul
    Yasar, Zeynep Yuksel
    Bal, Hamit
    Kinikoglu, Oguzcan
    Oksuz, Sila
    Ozkerim, Ugur
    Tunbekici, Salih
    Yildiz, Hacer Sahika
    Alan, Ozkan
    Coban Kokten, Sermin
    Isik, Deniz
    Surmeli, Heves
    Basoglu, Tugba
    Sever, Ozlem Nuray
    Odabas, Hatice
    Yildirim, Mahmut Emre
    Turan, Nedim
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Predictors of Response and Survival Outcomes of Triple Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
    Zhu, Meizhen
    Yu, Yang
    Shao, Xiying
    Zhu, Liang
    Wang, Linbo
    CHEMOTHERAPY, 2020, 65 (3-4) : 101 - 109
  • [37] Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
    Romero, A.
    Garcia-Saenz, J. A.
    Fuentes-Ferrer, M.
    Lopez Garcia-Asenjo, J. A.
    Furio, V.
    Roman, J. M.
    Moreno, A.
    de la Hoya, M.
    Diaz-Rubio, E.
    Martin, M.
    Caldes, T.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 655 - 661
  • [38] Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival
    Precht, Lisa M.
    Lowe, Kimberly A.
    Atwood, Mary
    Beatty, J. David
    BREAST JOURNAL, 2010, 16 (04): : 362 - 368
  • [39] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    CANCER RESEARCH, 2022, 82 (04)
  • [40] THE METAL CLIPS AS BREAST CANCER MARKERS IN ASSESSMENT OF RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY
    Gambarova, G. H.
    Asgarova, H. E.
    Aghamaliyeva, A. J.
    Panahova, M. S.
    Agabeyli, L. Z.
    Qorchiyeva, G. S.
    WORLD OF MEDICINE AND BIOLOGY, 2024, 88 (02): : 28 - 32
12345